Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

New Zealand (NZX) Healthcare Sector Analysis

UpdatedMay 30, 2026
DataAggregated Company Financials
Companies14
  • 7D6.6%
  • 3M-10.7%
  • 1Y-9.2%
  • YTD-10.1%

The Healthcare industry is up 6.6% in the last week, with Fisher & Paykel Healthcare up 9.4%. In contrast, the industry has lost 9.2% in the last 12 months. Looking forward, earnings are forecast to grow by 23% annually.

Sector Valuation and Performance

Has the New Zealand Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 30 May 2026NZ$31.7bNZ$20.0bNZ$825.7m17.5x38.4x1.6x
Mon, 27 Apr 2026NZ$31.2bNZ$20.0bNZ$452.0m18.1x69.1x1.6x
Wed, 25 Mar 2026NZ$31.3bNZ$19.7bNZ$447.2m18.1x70.1x1.6x
Fri, 20 Feb 2026NZ$33.1bNZ$18.6bNZ$539.1m20.5x61.4x1.8x
Sun, 18 Jan 2026NZ$35.8bNZ$18.3bNZ$535.0m21.2x66.9x2x
Tue, 16 Dec 2025NZ$35.3bNZ$18.2bNZ$532.1m21.6x66.4x1.9x
Thu, 13 Nov 2025NZ$35.6bNZ$18.0bNZ$579.3m20.1x61.5x2x
Sat, 11 Oct 2025NZ$34.3bNZ$17.8bNZ$575.5m19.5x59.7x1.9x
Mon, 08 Sep 2025NZ$34.9bNZ$17.5bNZ$569.7m18.3x61.2x2x
Wed, 06 Aug 2025NZ$36.4bNZ$17.6bNZ$571.9m18.9x63.6x2.1x
Fri, 04 Jul 2025NZ$35.5bNZ$17.5bNZ$568.7m16.7x62.5x2x
Sun, 01 Jun 2025NZ$34.7bNZ$17.4bNZ$567.9m15x61.1x2x
Tue, 29 Apr 2025NZ$33.7bNZ$17.2bNZ$653.2m15.3x51.6x2x
Thu, 27 Mar 2025NZ$32.9bNZ$17.5bNZ$659.0m17.5x49.9x1.9x
Sat, 22 Feb 2025NZ$35.2bNZ$17.6bNZ$706.8m16.7x49.9x2x
Mon, 20 Jan 2025NZ$37.2bNZ$18.3bNZ$735.3m14.2x50.6x2x
Wed, 18 Dec 2024NZ$36.6bNZ$18.2bNZ$727.4m13.2x50.3x2x
Fri, 15 Nov 2024NZ$37.7bNZ$18.2bNZ$967.8m17.4x39x2.1x
Sun, 13 Oct 2024NZ$37.8bNZ$18.3bNZ$968.0m19.9x39.1x2.1x
Tue, 10 Sep 2024NZ$37.1bNZ$18.0bNZ$962.5m20.8x38.5x2.1x
Thu, 08 Aug 2024NZ$34.3bNZ$17.5bNZ$972.5m19x35.3x2x
Sat, 06 Jul 2024NZ$29.8bNZ$17.6bNZ$974.9m16.4x30.5x1.7x
Mon, 03 Jun 2024NZ$30.0bNZ$17.3bNZ$1.2b12.9x24.9x1.7x
Wed, 01 May 2024NZ$30.6bNZ$17.4bNZ$1.3b24x23.7x1.8x
Fri, 29 Mar 2024NZ$29.2bNZ$17.3bNZ$1.3b23.6x22.7x1.7x
Sun, 25 Feb 2024NZ$28.7bNZ$16.9bNZ$1.1b18.2x25.4x1.7x
Tue, 23 Jan 2024NZ$28.7bNZ$16.7bNZ$1.1b22.8x25.4x1.7x
Thu, 21 Dec 2023NZ$28.9bNZ$16.7bNZ$1.1b23.4x25.6x1.7x
Sat, 18 Nov 2023NZ$28.3bNZ$16.5bNZ$1.1b27x25.5x1.7x
Mon, 16 Oct 2023NZ$27.3bNZ$16.3bNZ$1.1b31x24.7x1.7x
Wed, 13 Sep 2023NZ$28.1bNZ$16.6bNZ$1.1b29x25.3x1.7x
Fri, 11 Aug 2023NZ$29.3bNZ$15.8bNZ$1.1b28.9x27.3x1.9x
Sun, 09 Jul 2023NZ$30.7bNZ$15.7bNZ$1.1b29.7x28.6x2x
Tue, 06 Jun 2023NZ$30.7bNZ$15.9bNZ$1.1b32.8x28.5x1.9x
Price to Earnings Ratio

28.5x


Total Market Cap: NZ$30.7bTotal Earnings: NZ$1.1bTotal Revenue: NZ$15.9bTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Healthcare Sector Price to Earnings3Y Average 44.4x202420252026
Current Industry PE
  • Investors are pessimistic on the New Zealander Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 38.4x which is lower than its 3-year average PE of 44.4x.
  • The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 8.5% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the New Zealand Healthcare sector?

NZ Market1.85%
Healthcare6.57%
Medical Equipment9.35%
Biotech3.70%
Pharma1.95%
Healthcare Services0.68%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 81.8x.
    • Analysts are expecting annual earnings growth of 14.5%, which is lower than the prior year's growth of 24.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 65% over the next 5 years.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 14% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
FPH Fisher & Paykel HealthcareNZ$37.299.4%
+NZ$1.9b		2.2%PE46.7x
RYM Ryman HealthcareNZ$2.263.7%
+NZ$80.8m		7.6%PS2.7x
SUM Summerset Group HoldingsNZ$8.024.2%
+NZ$77.9m		-27.4%PE7.5x
OCA Oceania HealthcareNZ$0.789.2%
+NZ$47.1m		23.0%PE4716.6x
PEB Pacific EdgeNZ$0.283.7%
+NZ$11.7m		241.5%PS24.1x

Latest News

FPH
NZ$37.29
Fisher & Paykel Healthcare
7D
9.4%
1Y
2.2%
AFT
NZ$3.93
AFT Pharmaceuticals
7D
1.3%
1Y
37.9%
Analysis Article • 12h

AFT Pharmaceuticals' (NZSE:AFT) Profits Appear To Have Quality Issues

Following the solid earnings report from AFT Pharmaceuticals Limited ( NZSE:AFT ), the market responded by bidding up...
PHL
NZ$0.66
Promisia Healthcare
7D
23.4%
1Y
88.6%
RYM
NZ$2.26
Ryman Healthcare
7D
3.7%
1Y
7.6%
TAH
NZ$4.80
Third Age Health Services
7D
-2.0%
1Y
47.7%
PEB
NZ$0.28
Pacific Edge
7D
3.7%
1Y
241.5%
OCA
NZ$0.78
Oceania Healthcare
7D
9.2%
1Y
23.0%
BLT
NZ$0.017
BLIS Technologies
7D
13.3%
1Y
6.3%
EBO
NZ$19.52
EBOS Group
7D
-3.6%
1Y
-47.3%
Narrative Update • May 19

EBO: Index Removal And Discount Rate Shift Will Support Capital Efficiency Reassessment

Analysts now cite a slightly lower fair value estimate for EBOS Group, trimming the indicative price target from around NZ$33.63 to NZ$33.31 as modest adjustments to the discount rate, profit margin and assumed future P/E feed through their models. What's in the News EBOS Group Limited (ASX:EBO) was removed from the S&P/ASX 200 Index.
SUM
NZ$8.02
Summerset Group Holdings
7D
4.2%
1Y
-27.4%